Osteomyelitis infection disguised as Reiter's syndrome in a child: A case report

Opara, Nnennaya U

doi:10.1002/ccr3.5219

Cited by 2 publications

(2 citation statements)

References 5 publications

(9 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Another common bone involvement in sickle cell disease patient is osteonecrosis. Osteonecrosis in sickle cell patients tends to affect a larger bone surface area than osteonecrosis due to other etiologies [ 18 ]. According to several works of literature, the increased risk of osteonecrosis of the femoral head in our patient group could be linked to an overall reduction in bone mineral density and marrow hyperplasia compared to the general population [ 18 , 19 ].…”

Section: Discussionmentioning

confidence: 99%

Management of Salter–Harris Type 1 Fracture Complicated with Osteomyelitis in a Sickle Cell Disease Patient: A Case Report and Review of Literature

2022

View full text Add to dashboard Cite

Salter–Harris fractures may occur due to a single injury or repetitive stress fractures on the extremities. Type I to III fractures are managed medically, while types IV and V, which are rare, are treated surgically. In the pediatric population, Salter–Harris I fractures of the distal tibia are commonly seen, and management of such fractures are well established in the literature. Despite the availability of a wide range of treatment for such fractures, osteonecrosis or avascular necrosis of the proximal femur can subsequently develop. Avascular necrosis is cell death secondary to metabolic disturbances, trauma, adverse effects of certain medications, or sickle cell disease. Avascular necrosis commonly affects the talus, humerus, or tibia in addition to the femoral head. Radiographic images are essential for prompt diagnosis and to minimize negative health outcomes in these patients. However, Salter–Harris I fracture in sickle cell patients can be very challenging due to these patients’ vulnerability to bone infections and sickle cell crisis. In this case report, our patient with a history of sickle cell disease and with a diagnosis of Salter–Harris I fracture was treated with surgical intervention as type V, which is discussed in this article, and responded well to treatment. Thus, this case suggests a new approach to managing Salter–Harris I fractures complicated with osteomyelitis in sickle cell patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Management of Salter–Harris Type 1 Fracture Complicated with Osteomyelitis in a Sickle Cell Disease Patient: A Case Report and Review of Literature

2022

View full text Add to dashboard Cite

show abstract

“…It is also worthwhile noting that although we did not include studies conducted on children in this systematic review, there could be a role of NTG in in treating LE especially in older children. However, before considering NTG in those cases, it will be important to consider osteomyelitis and Reiter's syndrome in children before making a clinical diagnosis of LE [ 16 , 17 ].…”

Section: Reviewmentioning

confidence: 99%

Management of Lateral Epicondylitis Using Transdermal Nitroglycerin: A Systematic Review

McCulloch¹,

Hunter²,

Lipp³

et al. 2022

Cureus

View full text Add to dashboard Cite

Lateral epicondylitis (LE), also known as tennis elbow, is an overuse tendinopathy originating from the forearm extensor tendons of the elbow. An emerging therapy for the treatment of LE is the use of transdermal nitroglycerin (NTG) patches for pain relief and improved function. The aim of this systematic review was to assess the current literature on the effect of a transdermal NTG patch for the treatment of LE. A literature search using MEDLINE, EMBASE, SportDiscus, and the Cochrane Database of Systematic Reviews was conducted. Studies selected for inclusion were those in which patients were clinically diagnosed with LE, RCTs, observational studies, and only articles published in English. Studies were excluded if they involved patients <18 years of age or involved patients with a potential alternative source of elbow pain such as previous surgery to the elbow, a previous history of dislocation, fracture of the elbow or tendon rupture, or a referred pain source such as cervical radiculopathy or peripheral nerve involvement. Studies were also excluded if they involved patients who were already prescribed topical NTG for any other indication (i.e., angina), and if the studies had no measurement of symptom relief or measurement or functional scoring. The initial search strategy yielded 69 articles, out of which four met the eligibility criteria and were included in this systematic review. The studies showed improvement in elbow pain in the shortterm and mid-term (up to six months), while one study that followed participants for a five-year duration post-treatment, showed no benefit. Three studies used an effective NTG dose of 1.25mg/24h and one study used an effective dose of 1.44mg/24h. Topical NTG was more effective when combined with a tendon rehabilitation program. The most commonly reported side effects of topical NTG were headaches and dermatitis. Overall, the current literature demonstrates that the use of NTG patches for LE improves shortand mid-term pain as well as elbow function. However, more studies are required to fully understand the effect of topical NTG on LE, particularly the effective dose range and the long-term benefits.

show abstract

Osteomyelitis infection disguised as Reiter's syndrome in a child: A case report

Cited by 2 publications

References 5 publications

Management of Salter–Harris Type 1 Fracture Complicated with Osteomyelitis in a Sickle Cell Disease Patient: A Case Report and Review of Literature

Management of Salter–Harris Type 1 Fracture Complicated with Osteomyelitis in a Sickle Cell Disease Patient: A Case Report and Review of Literature

Management of Lateral Epicondylitis Using Transdermal Nitroglycerin: A Systematic Review

Contact Info

Product

Resources

About